{
  "pmcid": "8928091",
  "sha256": "2aa046b1ae8563d0cfe290e5096591929cc798d19b4ce8f351fecbcc756039c3",
  "timestamp_utc": "2025-11-09T23:00:01.915320+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.289440366972482,
    "reading_ease": 19.198105504587176,
    "word_count": 218
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Early Supplemental Parenteral Nutrition in Abdominal Surgery: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised 1:1 to E-SPN (day 3) or L-SPN (day 8) groups. Randomisation used a permuted block design"
      },
      "Participants": {
        "score": 2,
        "evidence": "included 230 patients who met eligibility criteria, including an NRS-2002 score of ≥3 and ≤30% energy intake from EN on postoperative day 2"
      },
      "Intervention": {
        "score": 2,
        "evidence": "E-SPN (day 3) or L-SPN (day 8) groups"
      },
      "Objective": {
        "score": 1,
        "evidence": "aimed to evaluate the effect of early supplemental parenteral nutrition (E-SPN) versus late supplemental parenteral nutrition (L-SPN) on nosocomial infections"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of nosocomial infections from postoperative day 3 to discharge"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation used a permuted block design with allocation concealment via sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Conducted in 11 tertiary hospitals in China from April 1, 2017, to December 31, 2018, the trial included 230 patients"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of 230 randomised, 229 were analysed (115 E-SPN, 114 L-SPN) using intention-to-treat"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "E-SPN significantly reduced nosocomial infections (8.7% vs 18.4%; risk difference, 9.7%; 95% CI, 0.9%-18.5%; P = 0.04)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant differences in noninfectious complications or adverse events were observed"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial Registration: ClinicalTrials.gov Identifier: NCT03115957"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 22,
    "max_score": 25
  }
}